 |
 |
|
|
RESÚMENES FEBRERO 2005 |
Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers
(Requiere estar conectado a internet.
Haga un click en la información del journal)
Cluster analysis
of obsessive-compulsive spectrum disorders in patients with
obsessive-compulsive disorder: clinical and genetic correlates
Christine Lochner,
Sian M.J. Hemmings, Craig J. Kinnear, Dana J.H. Niehaus, Daniel G. Nel, Valerie
A. Corfield, Johanna C. Moolman-Smook, Soraya Seedat and Dan J. Stein
Comprehensive Psychiatry. Volume 46, Issue 1,
January-February 2005, Pages 14-19
Impulse control disorders in patients with
obsessive
LEONARDO F. FONTENELLE, MAURO V. MENDLOWICZ, AND
MARCIO VERSIANI
Psychiatry and Clinical Neurosciences Volume
59 Issue 1 Page 30 - February 2005
St John's wort
for depression. Meta-analysis of randomised controlled trials*
KLAUS LINDE, MICHAEL BERNER, MATTHIAS EGGER, CYNTHIA MULROW
The British Journal of Psychiatry (2005) 186: 99-107
Bupropion and
venlafaxine responders differ in pretreatment regional cerebral metabolism in
unipolar depression
John T. Little,
Terence A. Ketter, Tim A. Kimbrell, Robert T. Dunn, Brenda E. Benson, Mark W.
Willis, David A. Luckenbaugh and Robert M. Post
Biological Psychiatry. Volume 57, Issue 3, 1 February
2005, Pages 220-228
Neurochemical
markers for schizophrenia, bipolar disorder, and major depression in postmortem
brains
E. Fuller Torrey,
Beata M. Barci, Maree J. Webster, John J. Bartko, James H. Meador-Woodruff and
Michael B. Knable
Biological Psychiatry. Volume 57, Issue 3, 1 February
2005, Pages 252-260
Michael A.
Posternak, and Mark Zimmerman
J Clin Psychiatry 2005;66:148-158
A Randomized Controlled Trial of Venlafaxine Extended Release in Generalized Social Anxiety Disorder
Michael R.
Liebowitz, Richard M. Mangano, Jacques Bradwejn, and Gregory Asnis
J Clin Psychiatry 2005;66:238-247
Time to remission and relapse after the first hospital admission in severe
bipolar disorder
Evelyn J. Bromet,
Stephen J. Finch, Gabrielle A. Carlson,
Laura Fochtmann, Ramin Mojtabai, Thomas J. Craig,
Sun Kang and Qing Ye
Social Psychiatry and Psychiatric Epidemiology
2005;Volume 40, Number 2: 106 - 113
The effect of
chronic antidepressant treatment on serum brain-derived neurotrophic factor levels
in depressed patients: a preliminary study
Omer Aydemir,
Artuner Deveci and Fatma Taneli
James L. Abelson,
George C. Curtis and Thomas W. Uhde
Psychoneuroendocrinology. Volume 30, Issue 1, January
2005, Pages 72-79
Peter
J. Schmidt, Robert C. Daly, Miki Bloch, Mark J. Smith, Merry A. Danaceau, Linda
Simpson St. Clair, Jean H. Murphy, Nazli Haq, David R. Rubinow
Arch Gen Psychiatry. 2005;62:154-162
Robert
D. Gibbons, Kwan Hur, Dulal K. Bhaumik, J. John Mann
Arch Gen Psychiatry. 2005;62:165-172
The Structure of Genetic and Environmental Risk Factors for Anxiety Disorders in Men and Women
John
M. Hettema, Carol A. Prescott, John M. Myers, Michael C. Neale, Kenneth S.
Kendler
Arch Gen Psychiatry. 2005;62:182-189
Michael
R. Liebowitz, Alan J. Gelenberg, Dennis Munjack
Arch Gen Psychiatry. 2005;62:190-198
Mood changes
related to antidepressants: a longitudinal study of patients with bipolar
disorder in a naturalistic setting
Michael Bauer,
Natalie Rasgon, Paul Grof, Lori Altshuler, Laszlo Gyulai, Manfred Lapp, Tasha
Glenn and Peter C. Whybrow
Psychiatry Research. Volume 133, Issue 1, 30 January
2005, Pages 73-80
Toward an
objective characterization of an anhedonic phenotype: A signal-detection
approach
Diego A.
Pizzagalli, Allison L. Jahn and James P. O’Shea
Biological Psychiatry. Volume 57, Issue 4, 15 February
2005, Pages 319-327
An open-label
trial of the glutamate-modulating agent riluzole in combination with lithium
for the treatment of bipolar depression
Carlos A. Zarate,
Jr., Jorge A. Quiroz, Jaskaran B. Singh, Kirk D. Denicoff, Georgette De Jesus,
David A. Luckenbaugh, Dennis S. Charney and Husseini K. Manji
Biological Psychiatry. Volume 57, Issue 4, 15 February
2005, Pages 430-432
Cortisol response to diazepam: its relationship to
age, dose, duration of treatment, and presence of generalized anxiety disorder
Nunzio Pomara,
Lisa M Willoughby, John J Sidtis, Thomas B Cooper
and David J Greenblatt
Psychopharmacology 2005; Volume 178, Number 1: 1
- 8
Differential effects of reboxetine and citalopram on hand-motor function
in patients suffering from major depression
Ulrich Hegerl,
Roland Mergl, Verena Henkel, Oliver Pogarell,
Florian Müller-Siecheneder, Thomas Frodl and Georg Juckel
Psychopharmacology 2005; Volume 178, Number 1: 58
- 66
Helen C. Kales, Daniel F. Maixner, and Alan M. Mellow
Am J Geriatr Psychiatry 13:88-98, February 2005
Symptom Profile of DSM-IV Major and Minor Depressive Disorders in First-Ever Stroke Patients
Gianfranco Spalletta, Alessandra
Ripa, and Carlo Caltagirone
Am J Geriatr Psychiatry 13:108-115, February 2005
David F. Tolin, Julie T. Robison, Sonia Gaztambide, and Karen Blank
Am J Geriatr Psychiatry 13:150-156, February 2005
The dark side of bipolarity: detecting
bipolar depression in its pleomorphic expressions
Hagop S. Akiskal
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 107-115
Charles L. Bowden
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 117-125
Bipolar II vs.
unipolar depression: psychopathologic differentiation by dimensional measures
Elie G. Hantouche and Hagop S. Akiskal
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 127-132
Dimensional
psychopathology of depression: detection of an ‘activation’ dimension in
unipolar depressed outpatients
M. Biondi, A.
Picardi, M. Pasquini, P. Gaetano and P. Pancheri
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 133-139
Diagnostic
conversion from depression to bipolar disorders: results of a long-term
prospective study of hospital admissions
Jules Angst, Robert
Sellaro, Hans H. Stassen and Alex Gamma
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 149-157
Alessandro Serretti
and Paolo Olgiati
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 159-166
The high prevalence
of bipolar spectrum disorders in young adults with recurrent depression: toward
an innovative diagnostic framework
Daniel J. Smith,
Nadine Harrison, Walter Muir and Douglas H. R. Blackwood
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 167-178
High rate of
unrecognized bipolar mixed states among destitute Hispanic adolescents referred
for “major depressive disorder”
Steven C. Dilsaver
and Hagop S. Akiskal
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 179-186
Irritable
psychomotor elation in depressed inpatients: a factor validation of mixed
depression
T. Sato, R.
Bottlender, N. Kleindienst and H. -J. Möller
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 187-196
Hagop S. Akiskal
and Franco Benazzi
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 209-217
Franco Benazzi and
Hagop Akiskal
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 197-207
Franco Benazzi and
Hagop S. Akiskal
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 225-232
Ketil Joachim
Oedegaard and Ole Bernt Fasmer
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 233-242
Mood stabilizer
augmentation in apparently "unipolar" MDD: predictors of response in
the naturalistic French national EPIDEP study
Elie G. Hantouche,
H. S. Akiskal, S. Lancrenon and L. Chatenêt-Duchêne
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 243-249
Verinder Sharma,
Mustaq Khan and Angela Smith
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 251-257
Antidepressant-associated
chronic irritable dysphoria (acid) in bipolar disorder: a case series
Rif. S. EI-Mallakh
and Anoop Karippot
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 267-272
Searching for
behavioral indicators of bipolar II in patients presenting with major
depressive episodes: the “red sign,” the “rule of three” and other biographic
signs of temperamental extravagance, activation and hypomania
Hagop S. Akiskal
Journal of Affective Disorders. Volume 84, Issues 2-3,
February 2005, Pages 279-290
Hypericum extract LI 160 and fluoxetine in mild to moderate depression.
A randomized, placebo–controlled multi–center study in outpatients
L. Bjerkenstedt,
G. V. Edman, R. G. Alken and M. Mannel
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 255, Number 1: 40 - 47
Clinical outcome in patients with obsessive-compulsive disorder after
discontinuation of SRI treatment: results from a two–year follow–up
Andreas Kordon,
K. G. Kahl, A. Broocks, U. Voderholzer,
H. Rasche–Räuchle and F. Hohagen
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 255, Number 1: 48 - 50
Obsessive-compulsive syndromes and disorders. Significance of
comorbidity with bipolar and anxiety syndromes
Jules Angst,
Alex Gamma, Jérôme Endrass, Elie Hantouche, Renée Goodwin,
Vladeta Ajdacic, Dominique Eich and Wulf Rössler
European Archives of Psychiatry and Clinical
Neuroscience 2005; Volume 255, Number 1: 65 - 71
N. Kleindienst,
W. E. Severus, H.-J. Möller and W. Greil
European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 1: 72 - 74
Cluster analysis of obsessive-compulsive spectrum disorders in patients
with obsessive-compulsive disorder: clinical and genetic correlates
Christine Lochner, Sian M.J. Hemmings, Craig J.
Kinnear, Dana J.H. Niehaus, Daniel G. Nel, Valerie A. Corfield, Johanna C.
Moolman-Smook, Soraya Seedat, Dan J. Stein
Compr Psychiatry. January-February 2005 • Volume 46 •
Number 1
Comorbid personality disorders in subjects with panic disorder: do
personality disorders increase clinical severity?
Mustafa Ozkan, Abdurrahman Altindag
Compr Psychiatry. January-February 2005 • Volume 46 •
Number 1
George
I. Papakostas, Timothy Petersen, Dan V. Iosifescu, Alana
M. Burns, Andrew A. Nierenberg, Jonathan E. Alpert, Jerrold
F. Rosenbaum and Maurizio Fava
The International Journal of Neuropsychopharmacology
(2005), 8:1:59-63
Koen Demyttenaere,
Jürgen De Fruyt and Stephen M. Stahl
The International Journal of Neuropsychopharmacology
(2005), 8:1:93-105
Naomi
A. Fineberg and Tim M. Gale
The International Journal of Neuropsychopharmacology
(2005), 8:1:107-129
Amy
M. Kilbourne
Current Psychiatry Reports 2005, 7:10-17
Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review
David Gunnell,
Julia Saperia, Deborah Ashby
BMJ 2005;330:385 (19 February)
Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study
Carlos Martinez,
Stephan Rietbrock, Lesley Wise, Deborah Ashby, Jonathan Chick, Jane Moseley, Stephen Evans, David Gunnell
BMJ 2005;330:389 (19 February)
Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials
Dean Fergusson,
Steve Doucette, Kathleen Cranley Glass, Stan Shapiro, David Healy, Paul Hebert, Brian Hutton
BMJ 2005;330:396 (19 February)
The combined treatment of venlafaxine and ECT in
treatment-resistant depressive patients
Nesrin Dilbaz , Cem Sengül
, Tuncer Okay , Göksel Bayam , Ali Türkoglu
International Journal of Psychiatry in Clinical
Practice. Volume 9, Number 1 / March 2005:55 - 59
Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study
J. Douglas Bremner, Tanja Mletzko, Silke Welter, Sinead Quinn, Chanda
Williams, Marijn Brummer, Sajid Siddiq, Lai Reed, Christine M. Heim, Charles B.
Nemeroff
Journal of Psychopharmacology, Vol. 19, No. 2, 159-165
(2005)
Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram
Bárbara Arias, Rosa Catalán, Cristóbal Gastó, Blanca Gutiérrez, Lourdes
Fañanás
Journal of Psychopharmacology, Vol. 19, No. 2, 166-172
(2005)
Jordan F. Karp, Debra Weiner, Karen Seligman, Meryl Butters, Mark
Miller, Ellen Frank, Jacqueline Stack, Benoit H. Mulsant, Bruce Pollock, Mary
Amanda Dew, David J. Kupfer, and Charles F. Reynolds, III
Am J Geriatr Psychiatry 13:188-194, March 2005
J. Craig Nelson, Madelaine M. Wohlreich, Craig H. Mallinckrodt, Michael
J. Detke, John G. Watkin, and John S. Kennedy
Am
J Geriatr Psychiatry 13:227-235, March 2005
Discontinuation rates for selective serotonin reuptake inhibitors and
other second-generation antidepressants in outpatients with major depressive
disorder: a systematic review and meta-analysis
Gartlehner, Gerald; Hansen, Richard A;
Carey, Timothy S; Lohr, Kathleen N; Gaynes, Bradley N; Randolph, Leah
International Clinical Psychopharmacology. 20(2):59-69,
March 2005
The relationship between early changes in the HAMD-17
anxiety/somatization factor items and treatment outcome among depressed
outpatients
Farabaugh, Amy; Mischoulon, David; Fava,
Maurizio; Wu, Shirley L.; Mascarini, Alessandra; Tossani, Eliana; Alpert,
Jonathan E
International Clinical Psychopharmacology.
20(2):87-91, March 2005